These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2965429)

  • 21. Functional and immunologic protein S in normal pregnant women and in full-term newborns.
    Fernández JA; Estellés A; Gilabert J; España F; Aznar J
    Thromb Haemost; 1989 Jun; 61(3):474-8. PubMed ID: 2529662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APC-resistance as measured by a Textarin time assay: comparison to the APTT-based method.
    Hoagland LE; Triplett DA; Peng F; Barna L
    Thromb Res; 1996 Sep; 83(5):363-73. PubMed ID: 8873345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity.
    Seré KM; Janssen MP; Willems GM; Tans G; Rosing J; Hackeng TM
    Biochemistry; 2001 Jul; 40(30):8852-60. PubMed ID: 11467946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening of protein S deficiency using a functional assay in patients with venous and arterial thrombosis.
    Wiesel ML; Charmantier JL; Freyssinet JM; Grunebaum L; Schuhler S; Cazenave JP
    Thromb Res; 1990 Jun; 58(5):461-8. PubMed ID: 2142342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fast functional protein C assay using Protac, a novel protein C activator.
    Martinoli JL; Stocker K
    Thromb Res; 1986 Aug; 43(3):253-64. PubMed ID: 3526629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a new venom-based clotting assay of protein C.
    Cooper PC; Cooper SM; Goodfellow KJ; Hickey KP; Kitchen S; Makris M
    Int J Lab Hematol; 2008 Oct; 30(5):437-43. PubMed ID: 19046320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C.
    Mesters RM; Heeb MJ; Griffin JH
    Protein Sci; 1993 Sep; 2(9):1482-9. PubMed ID: 8401232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Edoxaban: Impact on routine and specific coagulation assays. A practical laboratory guide.
    Douxfils J; Chatelain B; Chatelain C; Dogné JM; Mullier F
    Thromb Haemost; 2016 Jan; 115(2):368-81. PubMed ID: 26510969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va.
    Mesters RM; Heeb MJ; Griffin JH
    Biochemistry; 1993 Nov; 32(47):12656-63. PubMed ID: 8251484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency.
    Bertina RM; Broekmans AW; Krommenhoek-van Es C; van Wijngaarden A
    Thromb Haemost; 1984 Feb; 51(1):1-5. PubMed ID: 6547008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.
    Koedam JA; Meijers JC; Sixma JJ; Bouma BN
    J Clin Invest; 1988 Oct; 82(4):1236-43. PubMed ID: 2971673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J; Meijer P; Vermylen J
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An improved test to identify aPC-resistant factor V-Leiden.
    Preda L; Erba N; Figini S; Carniti GC; Rossi E
    Thromb Res; 1997 Jun; 86(6):461-8. PubMed ID: 9219326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional activity of protein S determined with use of protein C activated by venom activator.
    Kobayashi I; Amemiya N; Endo T; Okuyama K; Tamura K; Kume S
    Clin Chem; 1989 Aug; 35(8):1644-8. PubMed ID: 2527095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.
    Petäjä J; Fernández JA; Gruber A; Griffin JH
    J Clin Invest; 1997 Jun; 99(11):2655-63. PubMed ID: 9169495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of plasma protein S--the protein cofactor of activated protein C.
    Bertina RM; van Wijngaarden A; Reinalda-Poot J; Poort SR; Bom VJ
    Thromb Haemost; 1985 Apr; 53(2):268-72. PubMed ID: 3161206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
    Wilmer M; Stocker C; Bühler B; Conell B; Calatzis A
    Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface.
    Mori T; Takeya H; Nishioka J; Gabazza EC; Suzuki K
    Thromb Haemost; 1996 Jan; 75(1):49-55. PubMed ID: 8713779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.